In 2003 Britain's Medicines and Healthcare Products Regulatory Agency (MHRA) analysed this and other GSK trials, and concluded that there was no evidence of paroxetine's efficacy and that there was a clear increase in suicidal behaviour in teenagers using it.
Britain's Medicines analysed this and other GSK trials. This was in 2003. Healthcare Products Regulatory Agency (MHRA) analysed this and other GSK trials. This was in 2003. Britain's Medicines concluded that there was no evidence of paroxetine's efficacy and that there was a clear increase in suicidal behaviour in teenagers. This was in 2003. Healthcare Products Regulatory Agency (MHRA) concluded that there was no evidence of paroxetine's efficacy and that there was a clear increase in suicidal behaviour in teenagers. This was in 2003. These teenagers were using it.